GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) - Stock Prices, Stock Peers & Analysis

Home
GLAXO.NS

Company Name	GlaxoSmithKline Pharmaceuticals Limited
Symbol	GLAXO.NS
Currency	INR
Price	2,698.35
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	457,116,680,100
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	1.59%
52-week-range	1,385.05 - 3,088
Industry	Drug Manufacturers—General
Sector	Healthcare
CEO	Mr. Bhushan Akshikar
Website	https://india-pharma.gsk.com

An error occurred while fetching data.

About GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM,